“…Developing a stimuli-sensitive nanocarrier system is a potential strategy for enhancing therapeutic efficacy and reducing adverse drug reactions. − A large range of pH-responsive nanocarriers have therefore been created and reported. Consequently, a wide variety of pH-responsive nanocarriers have been developed and described; however, those with pH-dependent charge conversion characteristics stand out as particularly intriguing and promising. , Wang et al reported an excellent pH-sensitive tumor-activated charge conversion delivery system, wherein this form boosts drug release, increases cellular absorption, and strengthens the killing effect on cancer cells. In healthy tissue (pH 6.5), the charge conversion nanocarriers are thought to be negatively charged and unable to easily interact with anionic biomacromolecules, which can prolong circulation time. , The positively charged nanocarriers can interact with negatively charged cell membranes in acidic tumor tissues (pH 7.4) to increase cellular absorption and therapeutic impact.…”